Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Brenneis, Christian ^a,b   Sisignano, Marco ^a   Coste, Ovidiu ^a   Altenrath, Kai ^a   Fischer, Michael J ^c   Angioni, Carlo ^a   Fleming, Ingrid ^a   Brandes, Ralf P ^a   Reeh, Peter W ^d   Woolf, Clifford J ^b   Geisslinger, Gerd ^a   Scholich, Klaus ^a  

^a GOETHE UNIVERSITY   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cyp450; Eet; Hyperalgesia; Nociceptors; Seh; Trpa1

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; 14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 8,9 EPOXYICOSATRIENOIC ACID; ALLYL ISOTHIOCYANATE; ARACHIDONIC ACID; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; CYCLOOXYGENASE 2; CYTOCHROME P450; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG; 8,9-EPOXYEICOSATRIENOIC ACID; DIHOMO GAMMA LINOLENIC ACID; DRUG DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRPA1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MALE; MECHANICAL STRESS; MOUSE; NEUROFILAMENT; NOCICEPTION; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PHENOTYPE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SCIATIC NERVE; SENSORY NERVE CELL; SPINAL GANGLION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; LIQUID CHROMATOGRAPHY; METABOLISM; MOUSE MUTANT; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; BLOTTING, WESTERN; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; EPOXIDE HYDROLASES; GANGLIA, SPINAL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TANDEM MASS SPECTROMETRY; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 80053476938     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-78     Document Type: Article

References (53)

1. Murakami M, Kudo I. Phospholipase A2. J Biochem 2002, 131:285-292.
2. Fleming I. Epoxyeicosatrienoic acids, cell signaling and angiogenesis. Prostaglandins Other Lipid Mediat 2007, 82:60-67. 10.1016/j.prostaglandins.2006.05.003, 17164133.
3. Larsen BT, Gutterman DD, Hatoum OA. Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur J Clin Invest 2006, 36:293-300. 10.1111/j.1365-2362.2006.01634.x, 16634832.
4. Scholich K, Geisslinger G. Is mPGES-1 a promising target for pain therapy?. Trends Pharmacol Sci 2006, 27:399-401. 10.1016/j.tips.2006.06.001, 16815559.
5. Zeilhofer HU, Brune K. Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci 2006, 27:467-474. 10.1016/j.tips.2006.07.007, 16876882.
6. Zweifel BS, Hardy MM, Anderson GD, Dufield DR, Pufahl RA, Masferrer JL. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors. Eur J Pharmacol 2008, 584:166-174. 10.1016/j.ejphar.2008.01.021, 18295198.
7. Conroy JL, Fang C, Gu J, Zeitlin SO, Yang W, Yang J, VanAlstine MA, Nalwalk JW, Albrecht PJ, Mazurkiewicz JE, et al. Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling. Nat Neurosci 13:284-286.
8. Fleming I. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation. Trends Pharmacol Sci 2007, 28:448-452. 10.1016/j.tips.2007.08.002, 17764757.
9. Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 2009, 50 Suppl:S52-56. 2674692, 18952572.
10. Chiamvimonvat N, Ho CM, Tsai HJ, Hammock BD. The soluble epoxide hydrolase as a pharmaceutical target for hypertension. J Cardiovasc Pharmacol 2007, 50:225-237. 10.1097/FJC.0b013e3181506445, 17878749.
11. Inceoglu B, Jinks SL, Schmelzer KR, Waite T, Kim IH, Hammock BD. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Life Sci 2006, 79:2311-2319. 10.1016/j.lfs.2006.07.031, 1904345, 16962614.
12. Inceoglu B, Jinks SL, Ulu A, Hegedus CM, Georgi K, Schmelzer KR, Wagner K, Jones PD, Morisseau C, Hammock BD. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc Natl Acad Sci USA 2008, 105:18901-18906. 10.1073/pnas.0809765105, 2596245, 19028872.
13. Fleming I, Rueben A, Popp R, Fisslthaler B, Schrodt S, Sander A, Haendeler J, Falck JR, Morisseau C, Hammock BD, Busse R. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells. Arterioscler Thromb Vasc Biol 2007, 27:2612-2618. 10.1161/ATVBAHA.107.152074, 17872452.
14. Loot AE, Popp R, Fisslthaler B, Vriens J, Nilius B, Fleming I. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation. Cardiovasc Res 2008, 80:445-452. 10.1093/cvr/cvn207, 18682435.
15. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003, 424:434-438. 10.1038/nature01807, 12879072.
16. Mizushima T, Obata K, Yamanaka H, Dai Y, Fukuoka T, Tokunaga A, Mashimo T, Noguchi K. Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesia. Pain 2005, 113:51-60. 10.1016/j.pain.2004.09.038, 15621364.
17. Alessandri-Haber N, Dina OA, Chen X, Levine JD. TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization. J Neurosci 2009, 29:6217-6228. 10.1523/JNEUROSCI.0893-09.2009, 2726836, 19439599.
18. Jordt SE, McKemy DD, Julius D. Lessons from peppers and peppermint: the molecular logic of thermosensation. Curr Opin Neurobiol 2003, 13:487-492. 10.1016/S0959-4388(03)00101-6, 12965298.
19. Pierre S, Maeurer C, Coste O, Becker W, Schmidtko A, Holland S, Wittpoth C, Geisslinger G, Scholich K. Toponomics analysis of functional interactions of the ubiquitin ligase PAM (Protein Associated with Myc) during spinal nociceptive processing. Mol Cell Proteomics 2008, 7:2475-2485. 10.1074/mcp.M800201-MCP200, 18753128.
20. Schubert W, Bonnekoh B, Pommer AJ, Philipsen L, Bockelmann R, Malykh Y, Gollnick H, Friedenberger M, Bode M, Dress AW. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol 2006, 24:1270-1278. 10.1038/nbt1250, 17013374.
21. Yu L, Yang F, Luo H, Liu FY, Han JS, Xing GG, Wan Y. The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant. Mol Pain 2008, 4:61. 10.1186/1744-8069-4-61, 2628345, 19055783.
22. Ueda H. Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination. Mol Pain 2008, 4:11. 10.1186/1744-8069-4-11, 2365930, 18377664.
23. Brenneis C, Coste O, Schmidt R, Angioni C, Popp L, Nusing RM, Becker W, Scholich K, Geisslinger G. Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice. J Cell Mol Med 2008, 12:639-648. 10.1111/j.1582-4934.2007.00110.x, 18419601.
24. Reinold H, Ahmadi S, Depner UB, Layh B, Heindl C, Hamza M, Pahl A, Brune K, Narumiya S, Muller U, Zeilhofer HU. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 2005, 115:673-679. 548700, 15719070.
25. Bernardini N, Neuhuber W, Reeh PW, Sauer SK. Morphological evidence for functional capsaicin receptor expression and calcitonin gene-related peptide exocytosis in isolated peripheral nerve axons of the mouse. Neuroscience 2004, 126:585-590. 10.1016/j.neuroscience.2004.03.017, 15183508.
26. Forster AB, Reeh PW, Messlinger K, Fischer MJ. High concentrations of morphine sensitize and activate mouse dorsal root ganglia via TRPV1 and TRPA1 receptors. Mol Pain 2009, 5:17. 10.1186/1744-8069-5-17, 2672059, 19371406.
27. da Costa DS, Meotti FC, Andrade EL, Leal PC, Motta EM, Calixto JB. The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation. Pain 148:431-437.
28. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Woolf CJ, Corey DP. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 2006, 50:277-289. 10.1016/j.neuron.2006.03.042, 16630838.
29. Wei H, Chapman H, Saarnilehto M, Kuokkanen K, Koivisto A, Pertovaara A. Roles of cutaneous versus spinal TRPA1 channels in mechanical hypersensitivity in the diabetic or mustard oil-treated non-diabetic rat. Neuropharmacology 58:578-584.
30. Newman JW, Morisseau C, Harris TR, Hammock BD. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci USA 2003, 100:1558-1563. 10.1073/pnas.0437724100, 149871, 12574510.
31. Deng Y, Theken KN, Lee CR. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol 48:331-341.
32. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999, 285:1276-1279. 10.1126/science.285.5431.1276, 2720027, 10455056.
33. Spiecker M, Liao JK. Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 2005, 433:413-420. 10.1016/j.abb.2004.10.009, 15581597.
34. Michaelis UR, Falck JR, Schmidt R, Busse R, Fleming I. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells. Arterioscler Thromb Vasc Biol 2005, 25:321-326.
35. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003, 170:1625-1629.
36. Inceoglu B, Lango J, Rabinovich A, Whetstone P, Hammock BD. The neutralizing effect of a polyclonal antibody raised against the N-terminal eighteen-aminoacid residues of birtoxin towards the whole venom of Parabuthus transvaalicus. Toxicon 2006, 47:144-149. 10.1016/j.toxicon.2005.08.018, 16356521.
37. Inceoglu B, Schmelzer KR, Morisseau C, Jinks SL, Hammock BD. Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). Prostaglandins Other Lipid Mediat 2007, 82:42-49. 10.1016/j.prostaglandins.2006.05.004, 1904338, 17164131.
38. Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 2005, 44:1-51. 10.1016/j.plipres.2004.10.001, 15748653.
39. Fang X, Hu S, Watanabe T, Weintraub NL, Snyder GD, Yao J, Liu Y, Shyy JY, Hammock BD, Spector AA. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors. J Pharmacol Exp Ther 2005, 314:260-270. 10.1124/jpet.105.085605, 1450258, 15798002.
40. Grau R, Punzon C, Fresno M, Iniguez MA. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. Biochem J 2006, 395:81-88. 10.1042/BJ20050964, 1409694, 16343055.
41. Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ. Epoxyeicosanoid signaling in CNS function and disease. Prostaglandins Other Lipid Mediat 2010, 91:68-84. 10.1016/j.prostaglandins.2009.06.004, 2844927, 19545642.
42. Kwan KY, Glazer JM, Corey DP, Rice FL, Stucky CL. TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci 2009, 29:4808-4819. 10.1523/JNEUROSCI.5380-08.2009, 2744291, 19369549.
43. Obata K, Noguchi K. MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci 2004, 74:2643-2653. 10.1016/j.lfs.2004.01.007, 15041446.
44. Materazzi S, Nassini R, Andre E, Campi B, Amadesi S, Trevisani M, Bunnett NW, Patacchini R, Geppetti P. Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. Proc Natl Acad Sci USA 2008, 105:12045-12050. 10.1073/pnas.0802354105, 2575298, 18687886.
45. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, Imamachi N, Andre E, Patacchini R, Cottrell GS, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci USA 2007, 104:13519-13524. 10.1073/pnas.0705923104, 1948902, 17684094.
46. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, Julius D. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006, 124:1269-1282. 10.1016/j.cell.2006.02.023, 16564016.
47. Fischer MJ, Reeh PW. Sensitization to heat through G-protein-coupled receptor pathways in the isolated sciatic mouse nerve. Eur J Neurosci 2007, 25:3570-3575. 10.1111/j.1460-9568.2007.05582.x, 17610576.
48. Sun RQ, Lawand NB, Lin Q, Willis WD. Role of calcitonin gene-related peptide in the sensitization of dorsal horn neurons to mechanical stimulation after intradermal injection of capsaicin. J Neurophysiol 2004, 92:320-326. 10.1152/jn.00086.2004, 15212441.
49. Eid SR, Crown ED, Moore EL, Liang HA, Choong KC, Dima S, Henze DA, Kane SA, Urban MO. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain 2008, 4:48. 10.1186/1744-8069-4-48, 2584039, 18954467.
50. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 2000, 275:40504-40510. 10.1074/jbc.M008106200, 11001943.
51. Linke B, Pierre S, Coste O, Angioni C, Becker W, Maier TJ, Steinhilber D, Wittpoth C, Geisslinger G, Scholich K. Toponomics analysis of drug-induced changes in arachidonic acid-dependent signaling pathways during spinal nociceptive processing. J Proteome Res 2009, 8:4851-4859. 10.1021/pr900106v, 19697962.
52. Coste O, Brenneis C, Linke B, Pierre S, Maeurer C, Becker W, Schmidt H, Gao W, Geisslinger G, Scholich K. Sphingosine 1-phosphate modulates spinal nociceptive processing. J Biol Chem 2008, 283:32442-32451. 10.1074/jbc.M806410200, 18805787.
53. Averbeck B, Reeh PW. Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin. Neuropharmacology 2001, 40:416-423. 10.1016/S0028-3908(00)00171-4, 11166334.